JP2023509512A5 - - Google Patents
Info
- Publication number
- JP2023509512A5 JP2023509512A5 JP2022541714A JP2022541714A JP2023509512A5 JP 2023509512 A5 JP2023509512 A5 JP 2023509512A5 JP 2022541714 A JP2022541714 A JP 2022541714A JP 2022541714 A JP2022541714 A JP 2022541714A JP 2023509512 A5 JP2023509512 A5 JP 2023509512A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- isolated
- chain
- population
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062957939P | 2020-01-07 | 2020-01-07 | |
| US62/957,939 | 2020-01-07 | ||
| PCT/US2021/012444 WO2021142081A1 (en) | 2020-01-07 | 2021-01-07 | Methods of producing t cell populations using induced pluripotent stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509512A JP2023509512A (ja) | 2023-03-08 |
| JP2023509512A5 true JP2023509512A5 (cg-RX-API-DMAC7.html) | 2023-11-15 |
| JP7793523B2 JP7793523B2 (ja) | 2026-01-05 |
Family
ID=74626090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541714A Active JP7793523B2 (ja) | 2020-01-07 | 2021-01-07 | 人工多能性幹細胞を用いたt細胞集団の製造方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230036952A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4087916A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7793523B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021142081A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021222479A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US9206394B2 (en) * | 2010-02-03 | 2015-12-08 | The University Of Tokyo | Method for reconstructing immune function using pluripotent stem cells |
| JPWO2011096482A1 (ja) * | 2010-02-03 | 2013-06-13 | 国立大学法人 東京大学 | 多能性幹細胞を用いた免疫機能再建法 |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| EP2853590B1 (en) * | 2012-05-22 | 2018-11-07 | The University of Tokyo | Method for producing antigen-specific t cells |
| JP6555058B2 (ja) * | 2015-09-30 | 2019-08-07 | アイシン精機株式会社 | 車両用画像処理装置 |
| CA3048996A1 (en) * | 2015-12-08 | 2017-06-15 | Regents Of The University Of Minnesota | Human t cell derived from t cell-derived induced pluripotent stem cell and methods of making and using |
| JP7653759B2 (ja) * | 2016-01-20 | 2025-03-31 | フェイト セラピューティクス,インコーポレイテッド | 養子免疫療法における免疫細胞調節のための組成物および方法 |
-
2021
- 2021-01-07 US US17/790,939 patent/US20230036952A1/en active Pending
- 2021-01-07 JP JP2022541714A patent/JP7793523B2/ja active Active
- 2021-01-07 EP EP21705663.9A patent/EP4087916A1/en active Pending
- 2021-01-07 WO PCT/US2021/012444 patent/WO2021142081A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220204933A1 (en) | Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens | |
| CN104321425B (zh) | 用于诱导和扩增源自外周血单个核细胞的自然杀伤细胞的方法 | |
| CA2848121C (en) | Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment | |
| JP2019536461A5 (cg-RX-API-DMAC7.html) | ||
| WO2019138217A1 (en) | Method for transducing cells with a viral vector for the expression of a chimeric antigen receptor (car) or transgenic t-cell receptor (tcr) | |
| WO2014017533A1 (ja) | T細胞受容体のクローニング方法 | |
| JP2020506713A (ja) | 多能性幹細胞から模倣自然免疫細胞を生成する方法及びキット | |
| KR20220031541A (ko) | 항-bcma car t 세포의 제조 | |
| Liang et al. | Single-cell transcriptomics reveals killing mechanisms of antitumor cytotoxic CD4+ TCR-T cells | |
| US20250152628A1 (en) | Tcr targeting cytomegalovirus antigen, t cell expressing tcr, and application | |
| US9205111B2 (en) | Process for producing engineered targeted T cell and medicine | |
| Manca et al. | Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS | |
| CN118591397A (zh) | 通用型car-t细胞的制备技术及其应用 | |
| US20220233596A1 (en) | Modified NK-92 cells, and therapeutic and diagnostic uses thereof | |
| CN113832101A (zh) | 自然杀伤细胞体外高效扩增的制备方法 | |
| JP7725014B2 (ja) | HTLV-1がコードするTax抗原特異的細胞傷害性Tリンパ球のT細胞受容体又はその機能的断片 | |
| EP4538366A1 (en) | Enhancing lineage stability of therapeutic regulatory t cell products | |
| CA2501087C (en) | Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer | |
| TW202615096A (zh) | SARS-CoV-2感染症治療及/或預防用細胞及其製法 | |
| JP2023504196A5 (cg-RX-API-DMAC7.html) | ||
| Chin et al. | T-cell receptor v-Beta usage of tumor-infiltrating lymphocyte lines cloned from human breast-tumor and melanoma | |
| JP2025515116A5 (cg-RX-API-DMAC7.html) | ||
| WO2025196582A1 (en) | A method for preparing chimeric antigen receptor (car) expressing cells | |
| CN121673419A (zh) | 一种工程化t细胞受体、表达其的现货型工程免疫细胞以及在肿瘤中的应用 | |
| WO2024190905A1 (ja) | Hpv特異的細胞傷害性t細胞のt細胞受容体又はその機能的断片 |